Workflow
Cancer Drugs
icon
Search documents
The Dark Side of Fast-Tracked Cancer Drugs | Exclusive Preview
Half of approved cancer drugs don't have proof they extend survival for any of their approved uses. We're spending enormous amounts of money on drugs where we don't really know how much they're actually going to help patients. The primary motive of a pharmaceutical industry is to generate profits for shareholders.There can be pressure to move clinical trials through quickly and approve medicines on perhaps uncertain evidence because there's massive financial forces behind that. If they become sick, it doesn ...